Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Association of “metabolic dysfunction-associated steatotic pancreas disease” (maspd) and insulin resistance

HIGHLIGHTS

  • Metabolic dysfunction-associated steatotic pancreas disease (MASPD) is a recent discovery in the world of metabolic disorders, and its potential connection to insulin resistance (IR) has sparked significant interest.
  • Pancreatic steatosis, a defining characteristic of MASPD, may disrupt the delicate balance of the pancreas, potentially hindering its ability to secrete insulin effectively.
  • The relationship between MASPD and IR is increasingly important for understanding the pathophysiology of both conditions and may have clinical implications in their prevention and management.
  • Research suggests a two-way street between MASPD and IR.

ABSTRACT – Background –

To investigate the association between metabolic dysfunction-associated steatotic pancreas disease (MASPD) and insulin resistance (IR).

Methods:  This cross-sectional study involved 157 participants diagnosed with MASPD based on ultrasonography criteria. Baseline demographic data were collected, including age, gender, and body mass index. Serum levels of fasting glucose, insulin, lipid profile (including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), glycated hemoglobin and insulin were measured using standardized laboratory techniques. Abdominal ultrasonography was performed on all participants using convex transducer (frequency range, 3,5 MHz) by experienced radiologist blinded to the clinical data. The association between MASPD and IR was assessed using logistic regression analysis, adjusting for potential confounders. Statistical significance was set at a P-value <0.05.

Results:  The logistic regression analysis was performed to verify whether MASPD was a risk factor for IR. After adjusting for gender and age, the results show a significant correlation between MASPD and markers of IR. TyG index: OR (95%IC) 5.72 (1.90-16.00), P 0.021, and HOMA -IR: OR (95%IC) 6.20 (2.1-22.00) P 0.037.

Conclusion:  This study presents a description of MASPD and its association with IR indices. Our findings show a significant correlation between MASPD and markers of IR. These results suggest that MASPD may contribute to the development of insulin resistance and further highlight the importance of pancreatic health in metabolic disorders.

 

AUTORES

ANDRADE, Luís Jesuino de Oliveira OLIVEIRA, Gabriela Correia Matos de BITTENCOURT, Alcina Maria Vinhaes BAPTISTA, Gustavo Magno SILVA, Catharina Peixoto OLIVEIRA, Luís Matos de